Atomoxetine
Pricing Report NDC 66993-042-30

Latest NADAC: $0.93246 per EA · Effective Aug 17, 2022 · Est. package price $27.97 (30 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Atomoxetine (NDC 66993-042-30) is $0.93246 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 17, 2022.

As a provided by Prasco Laboratories, this medication is distributed in a 30 CAPSULE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.93246
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Aug 17, 2022
Billable Units
30 EA
Estimated Package Price
$27.97
Data Status
As of Aug 17, 2022
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
66993-042-30
Description
30 CAPSULE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Aug 2017, the NADAC wholesale price for (NDC ) has moved within a range of $0.79580 to $3.55813 per EA. Over this 4 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.7958 - $3.5581
Market Volatility
347.11% Variance
Latest Trend
17.17%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 17, 2022 $0.93246 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 20, 2022 $0.79580 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 22, 2022 $0.95557 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 18, 2022 $0.90103 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 20, 2022 $1.07565 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 23, 2022 $1.05569 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 23, 2022 $1.03441 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 19, 2022 $1.05157 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 22, 2021 $1.10958 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 17, 2021 $1.45589 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 20, 2021 $1.22411 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 22, 2021 $1.24822 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026